MXPA02001009A - Virus de la influenza atenuado util como vacuna. - Google Patents

Virus de la influenza atenuado util como vacuna.

Info

Publication number
MXPA02001009A
MXPA02001009A MXPA02001009A MXPA02001009A MXPA02001009A MX PA02001009 A MXPA02001009 A MX PA02001009A MX PA02001009 A MXPA02001009 A MX PA02001009A MX PA02001009 A MXPA02001009 A MX PA02001009A MX PA02001009 A MXPA02001009 A MX PA02001009A
Authority
MX
Mexico
Prior art keywords
vaccine
virus
influenza virus
attenuated influenza
poly
Prior art date
Application number
MXPA02001009A
Other languages
English (en)
Inventor
Gow Brownlee George
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9917981.4A external-priority patent/GB9917981D0/en
Application filed by Isis Innovation filed Critical Isis Innovation
Publication of MXPA02001009A publication Critical patent/MXPA02001009A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation

Abstract

La presente invencion se refiere a un virus de ARN de una sola hebra, de sentido negativo, atenuado por el reemplazo del rastro de poly U en un acido nucleico genomico por un rastro de poly A el cual es capaz de ser copiado para proporcionar una extremidad de poly U para el ARNm transcrito desde el acido nucleico. El virus es tipicamente el virus de la influenza. El virus puede ser incorporado en una vacuna o utilizado como un virus auxiliador.
MXPA02001009A 1999-07-30 2000-07-28 Virus de la influenza atenuado util como vacuna. MXPA02001009A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14614599P 1999-07-30 1999-07-30
GBGB9917981.4A GB9917981D0 (en) 1999-07-30 1999-07-30 Viral vaccine
PCT/GB2000/002933 WO2001009291A1 (en) 1999-07-30 2000-07-28 Attenuated influenza virus useful as vaccine

Publications (1)

Publication Number Publication Date
MXPA02001009A true MXPA02001009A (es) 2002-10-31

Family

ID=26315811

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02001009A MXPA02001009A (es) 1999-07-30 2000-07-28 Virus de la influenza atenuado util como vacuna.

Country Status (9)

Country Link
EP (1) EP1200563B1 (es)
JP (1) JP2003508086A (es)
CN (1) CN1451038A (es)
AT (1) ATE308612T1 (es)
AU (1) AU6454700A (es)
CA (1) CA2380514A1 (es)
DE (1) DE60023708D1 (es)
MX (1) MXPA02001009A (es)
WO (1) WO2001009291A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ555118A (en) * 2004-11-11 2009-09-25 Solvay Biologicals Bv Defective influenza virus particles incapable of producing functional polymerase
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
JP2009512449A (ja) * 2005-10-19 2009-03-26 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド イヌにおける呼吸器疾患管理のための材料および方法
GB2437799B (en) * 2006-05-24 2008-08-13 Univ Warwick Defective interfering virus
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems

Also Published As

Publication number Publication date
EP1200563A1 (en) 2002-05-02
WO2001009291A1 (en) 2001-02-08
CA2380514A1 (en) 2001-02-08
DE60023708D1 (de) 2005-12-08
CN1451038A (zh) 2003-10-22
ATE308612T1 (de) 2005-11-15
EP1200563B1 (en) 2005-11-02
AU6454700A (en) 2001-02-19
JP2003508086A (ja) 2003-03-04

Similar Documents

Publication Publication Date Title
HUP0303036A3 (en) Dna transfection system for the generation of infectious influenza virus
WO2003079757A3 (en) Hiv therapeutic
WO2003089618A3 (en) Transposon system and methods of use
ATE420192T1 (de) Verfahren zur verringerung der antigenität des adeno-assoziierten virus strukturproteins
HK1161288A1 (en) Methods of producing knockdown cells or organisms by means of rna sequence- specific mediators of rna interference and uses thereof
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2003023005A3 (en) Antisense modulation of pka regulatory subunit rii alpha expression
NZ598000A (en) Composition for treating hbv infection
EP1394259A3 (en) Recombinant infectious non-segmented negative strand RNA virus
WO2006047683A3 (en) Antisense antiviral compound and method for treating influenza viral infection
DK0387775T3 (da) Genetisk enhed til inhibering af funktionen af RNA
WO2002044400A3 (en) Compositions and methods for extracting a nucleic acid
WO2000073764A3 (en) Composition and methods for the therapeutic use of an atonal-associated sequence
WO1998046788A3 (en) Primers and methods for the detection of disseminated tumor cells
WO2001032832A3 (en) Antisense inhibition of nucleolin expression
CA2361892A1 (en) Treatment of tumors with genetically engineered herpes virus
MXPA02001009A (es) Virus de la influenza atenuado util como vacuna.
MXPA03000061A (es) Manipulacion de virus de arn encadenados negativos mediante redisposicion de sus genes y usos de los mismos.
DK1175489T3 (da) Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
ES2286212T3 (es) Secuencias suprimidas especificamente del genoma de mycobacterium tuberculosis, y su uso en el diagnostico y como vacunas.
AU2003211947A1 (en) PRIMERS FOR NUCLEIC ACID AMPLIFICATION IN DETECTING HOUSEKEEPING GENE mRNA AND TEST METHOD USING THESE PRIMERS
ATE510545T1 (de) Zusammensetzungen und verfahren zur hemmung der expression von faktor v leiden mutationsgen
PT1272652E (pt) Virus de herpes para a modulacao imunitaria
WO2001048245A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof